re: Treatment for infant muscle wasting disease to hit market. potential price: $2 million

1) what were the R&D cost
2) what is the actual cost to produce a treatment regiment
3) what is the potential number of yearly patients that will use the drug
4) number of patients expected before ability to use generics.

Company should get a profit vs all the costs incurred. If not there will be no new drugs of this type.